Mitophagy in Huntington's disease

[1]  T. P. Neufeld,et al.  Fine-tuning autophagy maximises lifespan and is associated with changes in mitochondrial gene expression in Drosophila , 2020, PLoS genetics.

[2]  M. Vila,et al.  Mutant HTT (huntingtin) impairs mitophagy in a cellular model of Huntington disease , 2020, Autophagy.

[3]  N. Brustovetsky,et al.  Mutant huntingtin fails to directly impair brain mitochondria , 2019, Journal of neurochemistry.

[4]  M. Mattson,et al.  NAD+ in Brain Aging and Neurodegenerative Disorders. , 2019, Cell metabolism.

[5]  M. Eshraghi,et al.  Rhes, a striatal-enriched protein, promotes mitophagy via Nix , 2019, Proceedings of the National Academy of Sciences.

[6]  T. Intihar,et al.  Mitochondrial Dysfunction in Huntington’s Disease; Interplay Between HSF1, p53 and PGC-1α Transcription Factors , 2019, Front. Cell. Neurosci..

[7]  M. Z. Cader,et al.  Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease , 2019, Nature Neuroscience.

[8]  D. Mochly‐Rosen,et al.  Drp1/Fis1-mediated mitochondrial fragmentation leads to lysosomal dysfunction in cardiac models of Huntington's disease. , 2019, Journal of molecular and cellular cardiology.

[9]  Alexandre Benedetto,et al.  Autophagy promotes visceral aging in wild-type C. elegans , 2019, Autophagy.

[10]  A. Cuervo,et al.  Selective autophagy as a potential therapeutic target for neurodegenerative disorders , 2018, The Lancet Neurology.

[11]  M. Vila,et al.  Impairment of neuronal mitophagy by mutant huntingtin , 2018, bioRxiv.

[12]  G. Wells,et al.  Reversible Keap1 inhibitors are preferential pharmacological tools to modulate cellular mitophagy , 2017, Scientific Reports.

[13]  K. Mihara,et al.  Molecular basis of selective mitochondrial fusion by heterotypic action between OPA1 and cardiolipin , 2017, Nature Cell Biology.

[14]  S. Hersch,et al.  KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington's disease patients , 2017, Proceedings of the National Academy of Sciences.

[15]  M. Martínez-Vicente.  Neuronal Mitophagy in Neurodegenerative Diseases , 2017, Front. Mol. Neurosci..

[16]  D. Thiele,et al.  Abnormal degradation of the neuronal stress-protective transcription factor HSF1 in Huntington's disease , 2017, Nature Communications.

[17]  X. Qi,et al.  VCP cooperates with UBXD1 to degrade mitochondrial outer membrane protein MCL1 in model of Huntington's disease. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[18]  G. Wells,et al.  The pharmacological regulation of cellular mitophagy. , 2017, Nature chemical biology.

[19]  M. Orth,et al.  Mitochondrial cristae remodelling is associated with disrupted OPA1 oligomerisation in the Huntington's disease R6/2 fragment model , 2017, Experimental Neurology.

[20]  F. Goñi,et al.  Human Atg8-cardiolipin interactions in mitophagy: Specific properties of LC3B, GABARAPL2 and GABARAP , 2016, Autophagy.

[21]  G. Voeltz,et al.  Multiple Dynamin family members collaborate to drive mitochondrial division , 2016, Nature.

[22]  S. Chakrapani,et al.  VCP recruitment to mitochondria causes mitophagy impairment and neurodegeneration in models of Huntington's disease , 2016, Nature Communications.

[23]  R. Abagyan,et al.  SIRT2- and NRF2-Targeting Thiazole-Containing Compound with Therapeutic Activity in Huntington's Disease Models. , 2016, Cell chemical biology.

[24]  M. Duchen,et al.  Mitochondrial dynamics and quality control in Huntington's disease , 2016, Neurobiology of Disease.

[25]  D. Stojanovski,et al.  Cooperative and independent roles of the Drp1 adaptors Mff, MiD49 and MiD51 in mitochondrial fission , 2016, Journal of Cell Science.

[26]  L. Scorrano,et al.  Mito-Morphosis: Mitochondrial Fusion, Fission, and Cristae Remodeling as Key Mediators of Cellular Function. , 2016, Annual review of physiology.

[27]  J. Mears,et al.  Distinct Splice Variants of Dynamin-related Protein 1 Differentially Utilize Mitochondrial Fission Factor as an Effector of Cooperative GTPase Activity* , 2015, The Journal of Biological Chemistry.

[28]  J. Harper,et al.  The PINK1-PARKIN Mitochondrial Ubiquitylation Pathway Drives a Program of OPTN/NDP52 Recruitment and TBK1 Activation to Promote Mitophagy. , 2015, Molecular cell.

[29]  Geoff Wells,et al.  Design, Synthesis, and Evaluation of Triazole Derivatives That Induce Nrf2 Dependent Gene Products and Inhibit the Keap1-Nrf2 Protein-Protein Interaction. , 2015, Journal of medicinal chemistry.

[30]  J. Burman,et al.  The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy , 2015, Nature.

[31]  M. Disatnik,et al.  Impaired GAPDH-induced mitophagy contributes to the pathology of Huntington’s disease , 2015, EMBO molecular medicine.

[32]  N. Hattori,et al.  TBK1 controls autophagosomal engulfment of polyubiquitinated mitochondria through p62/SQSTM1 phosphorylation. , 2015, Human molecular genetics.

[33]  D. Komander,et al.  Mechanism of phospho-ubiquitin induced PARKIN activation , 2015, Nature.

[34]  N. Brustovetsky.  Mutant Huntingtin and Elusive Defects in Oxidative Metabolism and Mitochondrial Calcium Handling , 2015, Molecular Neurobiology.

[35]  A. Cuervo,et al.  HTT/Huntingtin in selective autophagy and Huntington disease: A foe or a friend within? , 2015, Autophagy.

[36]  Quan Chen,et al.  Selective removal of mitochondria via mitophagy: distinct pathways for different mitochondrial stresses. , 2015, Biochimica et biophysica acta.

[37]  W. Neupert,et al.  Cooperation of TOM and TIM23 complexes during translocation of proteins into mitochondria. , 2015, Journal of molecular biology.

[38]  M. L. Lachenmayer,et al.  Proteotoxic Stress Induces Phosphorylation of p62/SQSTM1 by ULK1 to Regulate Selective Autophagic Clearance of Protein Aggregates , 2015, PLoS genetics.

[39]  R. Youle,et al.  The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease , 2015, Neuron.

[40]  A. Aouane,et al.  PINK1-induced mitophagy promotes neuroprotection in Huntington's disease , 2015, Cell Death and Disease.

[41]  G. Wells,et al.  PMI: A ΔΨm Independent Pharmacological Regulator of Mitophagy , 2014, Chemistry & biology.

[42]  D. Housman,et al.  Potential function for the Huntingtin protein as a scaffold for selective autophagy , 2014, Proceedings of the National Academy of Sciences.

[43]  G. Johnson,et al.  Sulforaphane induces autophagy through ERK activation in neuronal cells , 2014, FEBS letters.

[44]  R. Morrison,et al.  p53 and mitochondrial function in neurons. , 2014, Biochimica et biophysica acta.

[45]  A. Brivanlou,et al.  Huntingtin protein is essential for mitochondrial metabolism, bioenergetics and structure in murine embryonic stem cells. , 2014, Developmental biology.

[46]  A. Ernst,et al.  Cargo recognition and trafficking in selective autophagy , 2014, Nature Cell Biology.

[47]  Oxana V. Baranova,et al.  Inhibition of mitochondrial protein import by mutant huntingtin , 2014, Nature Neuroscience.

[48]  T. Hirokawa,et al.  Ubiquitin is phosphorylated by PINK1 to activate parkin , 2014, Nature.

[49]  I. Rahman,et al.  Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52 , 2014, Nature Communications.

[50]  E. Holzbaur,et al.  The Regulation of Autophagosome Dynamics by Huntingtin and HAP1 Is Disrupted by Expression of Mutant Huntingtin, Leading to Defective Cargo Degradation , 2014, The Journal of Neuroscience.

[51]  S. Snyder,et al.  Rhes, a Striatal-selective Protein Implicated in Huntington Disease, Binds Beclin-1 and Activates Autophagy* , 2013, The Journal of Biological Chemistry.

[52]  M. Shamloo,et al.  Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration. , 2013, The Journal of clinical investigation.

[53]  G. Bonanno,et al.  Regulatory Flexibility , 2013, Perspectives on psychological science : a journal of the Association for Psychological Science.

[54]  G. Ramm,et al.  The protonophore CCCP interferes with lysosomal degradation of autophagic cargo in yeast and mammalian cells , 2013, Autophagy.

[55]  Simon C Watkins,et al.  Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells , 2013, Nature Cell Biology.

[56]  R. Youle,et al.  The accumulation of misfolded proteins in the mitochondrial matrix is sensed by PINK1 to induce PARK2/Parkin-mediated mitophagy of polarized mitochondria , 2013, Autophagy.

[57]  D. Llères,et al.  Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex , 2013, Proceedings of the National Academy of Sciences.

[58]  Julio C. B. Ferreira,et al.  Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Phosphorylation by Protein Kinase Cδ (PKCδ) Inhibits Mitochondria Elimination by Lysosomal-like Structures following Ischemia and Reoxygenation-induced Injury* , 2013, The Journal of Biological Chemistry.

[59]  D. Mochly‐Rosen,et al.  A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity , 2013, Journal of Cell Science.

[60]  E. Laplantine,et al.  Toward an integrative view of Optineurin functions , 2012, Cell cycle.

[61]  Miratul M. K. Muqit,et al.  PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65 , 2012, Open Biology.

[62]  David S. Park,et al.  Mitochondrial processing peptidase regulates PINK1 processing, import and Parkin recruitment , 2012, EMBO reports.

[63]  W. Saxton,et al.  Parkinson's Disease–Associated Kinase PINK1 Regulates Miro Protein Level and Axonal Transport of Mitochondria , 2012, PLoS genetics.

[64]  Vishwanath T. Anekonda,et al.  Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease. , 2012, Human molecular genetics.

[65]  N. Nukina,et al.  Serine 403 phosphorylation of p62/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins. , 2011, Molecular cell.

[66]  R. Scarpulla,et al.  Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. , 2011, Biochimica et biophysica acta.

[67]  Ann E. Frazier,et al.  MiD49 and MiD51, new components of the mitochondrial fission machinery , 2011, EMBO reports.

[68]  D. Selkoe,et al.  The mitochondrial intramembrane protease PARL cleaves human Pink1 to regulate Pink1 trafficking , 2011, Journal of neurochemistry.

[69]  A. Mesecar,et al.  Modification of keap1 cysteine residues by sulforaphane. , 2011, Chemical research in toxicology.

[70]  P. Hemachandra Reddy,et al.  Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage. , 2011, Human molecular genetics.

[71]  R. Youle,et al.  Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells , 2010, The Journal of cell biology.

[72]  R. Youle,et al.  p62/SQSTM1 is required for Parkin-induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for both , 2010, Autophagy.

[73]  Elsa Lauwers,et al.  Frontiers in Synaptic Neuroscience Synaptic Neuroscience , 2022 .

[74]  M. McMahon,et al.  p62/SQSTM1 Is a Target Gene for Transcription Factor NRF2 and Creates a Positive Feedback Loop by Inducing Antioxidant Response Element-driven Gene Transcription* , 2010, The Journal of Biological Chemistry.

[75]  N. Hattori,et al.  PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy , 2010, The Journal of cell biology.

[76]  D. Sulzer,et al.  CARGO RECOGNITION FAILURE IS RESPONSIBLE FOR INEFFICIENT AUTOPHAGY IN HUNTINGTON’S DISEASE , 2010, Nature Neuroscience.

[77]  M. DiFiglia,et al.  Polyglutamine expansion in huntingtin alters its interaction with phospholipids , 2009, Journal of neurochemistry.

[78]  T. Lithgow,et al.  Importing Mitochondrial Proteins: Machineries and Mechanisms , 2009, Cell.

[79]  Ji Zhang,et al.  Role of BNIP3 and NIX in cell death, autophagy, and mitophagy , 2009, Cell Death and Differentiation.

[80]  S. Snyder,et al.  Rhes, a Striatal Specific Protein, Mediates Mutant-Huntingtin Cytotoxicity , 2009, Science.

[81]  She Chen,et al.  ULK1·ATG13·FIP200 Complex Mediates mTOR Signaling and Is Essential for Autophagy* , 2009, Journal of Biological Chemistry.

[82]  G. Swarup,et al.  NF-κB Mediates Tumor Necrosis Factor α-Induced Expression of Optineurin, a Negative Regulator of NF-κB , 2009, PloS one.

[83]  C. Jung,et al.  ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. , 2009, Molecular biology of the cell.

[84]  J. Caviston,et al.  Huntingtin as an essential integrator of intracellular vesicular trafficking. , 2009, Trends in cell biology.

[85]  J. Guan,et al.  Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. , 2009, Molecular biology of the cell.

[86]  YongSung Kim,et al.  PINK1 controls mitochondrial localization of Parkin through direct phosphorylation. , 2008, Biochemical and biophysical research communications.

[87]  R. Youle,et al.  Parkin is recruited selectively to impaired mitochondria and promotes their autophagy , 2008, The Journal of cell biology.

[88]  G. Perkins,et al.  Mitochondrial fragmentation in neurodegeneration , 2008, Nature Reviews Neuroscience.

[89]  William Lin,et al.  Characterization of PINK1 processing, stability, and subcellular localization , 2008, Journal of neurochemistry.

[90]  A. M. van der Bliek,et al.  The novel tail-anchored membrane protein Mff controls mitochondrial and peroxisomal fission in mammalian cells. , 2008, Molecular biology of the cell.

[91]  He Li,et al.  N-Terminal Mutant Huntingtin Associates with Mitochondria and Impairs Mitochondrial Trafficking , 2008, The Journal of Neuroscience.

[92]  Guido Kroemer,et al.  Autophagy in the Pathogenesis of Disease , 2008, Cell.

[93]  Y. Ohsumi,et al.  Atg8, a Ubiquitin-like Protein Required for Autophagosome Formation, Mediates Membrane Tethering and Hemifusion , 2007, Cell.

[94]  Dimitri Krainc,et al.  Transcriptional Repression of PGC-1α by Mutant Huntingtin Leads to Mitochondrial Dysfunction and Neurodegeneration , 2006, Cell.

[95]  T. Shapiro,et al.  Safety, Tolerance, and Metabolism of Broccoli Sprout Glucosinolates and Isothiocyanates: A Clinical Phase I Study , 2006, Nutrition and cancer.

[96]  O. Andreassen,et al.  Effects of CAG repeat length, HTT protein length and protein context on cerebral metabolism measured using magnetic resonance spectroscopy in transgenic mouse models of Huntington's disease , 2005, Journal of neurochemistry.

[97]  S. Snyder,et al.  p53 Mediates Cellular Dysfunction and Behavioral Abnormalities in Huntington’s Disease , 2005, Neuron.

[98]  Lu Gan,et al.  Huntingtin phosphorylation on serine 421 is significantly reduced in the striatum and by polyglutamine expansion in vivo. , 2005, Human molecular genetics.

[99]  Yue Xiong,et al.  BTB Protein Keap1 Targets Antioxidant Transcription Factor Nrf2 for Ubiquitination by the Cullin 3-Roc1 Ligase , 2005, Molecular and Cellular Biology.

[100]  M. MacDonald,et al.  Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. , 2004, Human molecular genetics.

[101]  S. Orrenius,et al.  The cardiolipin-cytochrome c interaction and the mitochondrial regulation of apoptosis. , 2004, Archives of biochemistry and biophysics.

[102]  K. Itoh,et al.  Keap1-dependent Proteasomal Degradation of Transcription Factor Nrf2 Contributes to the Negative Regulation of Antioxidant Response Element-driven Gene Expression* , 2003, Journal of Biological Chemistry.

[103]  James R. Burke,et al.  Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines , 2002, Nature Neuroscience.

[104]  G. Courtois,et al.  Phorbol Esters and Cytokines Regulate the Expression of theNEMO-related Protein, a Molecule Involved in a NF-κB-independent Pathway* , 2000, The Journal of Biological Chemistry.

[105]  A. Hackam,et al.  Wild-Type Huntingtin Protects from Apoptosis Upstream of Caspase-3 , 2000, The Journal of Neuroscience.

[106]  J. Fahey,et al.  Antioxidant functions of sulforaphane: a potent inducer of Phase II detoxication enzymes. , 1999, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[107]  G P Bates,et al.  Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[108]  T. Shapiro,et al.  Human metabolism and excretion of cancer chemoprotective glucosinolates and isothiocyanates of cruciferous vegetables. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[109]  S. W. Davies,et al.  Intranuclear Neuronal Inclusions in Huntington's Disease and Dentatorubral and Pallidoluysian Atrophy: Correlation between the Density of Inclusions andIT15CAG Triplet Repeat Length , 1998, Neurobiology of Disease.

[110]  R. Albin,et al.  Ectopically Expressed CAG Repeats Cause Intranuclear Inclusions and a Progressive Late Onset Neurological Phenotype in the Mouse , 1997, Cell.

[111]  H. Braun,et al.  The mitochondrial processing peptidase. , 1997, The international journal of biochemistry & cell biology.

[112]  S. W. Davies,et al.  Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice , 1996, Cell.

[113]  S. Narumiya,et al.  Expanded polyglutamine in the Machado–Joseph disease protein induces cell death in vitro and in vivo , 1996, Nature Genetics.

[114]  J. Cooper,et al.  Mitochondrial defect in Huntington's disease caudate nucleus , 1996, Annals of neurology.

[115]  S. Snyder,et al.  A huntingtin-associated protein enriched in brain with implications for pathology , 1995, Nature.

[116]  J T Finch,et al.  Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[117]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[118]  C. Cho,et al.  A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[119]  Nektarios Tavernarakis,et al.  Mitophagy and Neuroprotection. , 2019, Trends in molecular medicine.

[120]  Vanita Chopraa,et al.  1-modifying small molecule reveals muted NRF 2 signaling responses in neural stem cells from Huntington disease patients , 2017 .

[121]  R. Abagyan,et al.  SIRT 2-and NRF 2-Targeting Thiazole-Containing Compound with Therapeutic Activity in Huntington ’ s Disease Models Highlights , 2016 .

[122]  X. Qi,et al.  VCP cooperates with UBXD 1 to degrade mitochondrial outer membrane protein MCL 1 in model of Huntington ' s disease , 2016 .

[123]  N. Hattori,et al.  TBK 1 controls autophagosomal engulfment of polyubiquitinated mitochondria through p 62 / SQSTM 1 phosphorylation , 2015 .

[124]  T. Johansen,et al.  Selective autophagy. , 2013, Essays in biochemistry.

[125]  B. Yue,et al.  Cellular and molecular biology of optineurin. , 2012, International review of cell and molecular biology.